What is the gold‑standard confirmatory laboratory test with the highest diagnostic yield for both qualitative and quantitative identification of sickle cell anemia?

Gold Standard Diagnostic Test for Sickle Cell Anemia

Hemoglobin electrophoresis (cellulose acetate at alkaline pH), isoelectric focusing, or cation-exchange high-performance liquid chromatography (CE-HPLC) are the gold standard confirmatory tests for both qualitative and quantitative identification of sickle cell anemia, with CE-HPLC increasingly preferred due to its superior quantitative capabilities.

Primary Diagnostic Approach

The definitive diagnosis of sickle cell disease requires hemoglobin separation techniques that can both identify the presence of hemoglobin S (HbS) and quantify the different hemoglobin fractions 1. These methods include:

• Cation-exchange HPLC (CE-HPLC): Most commonly used in modern laboratories, provides precise quantification of HbS, HbA, HbA2, and HbF percentages 2, 1
• Isoelectric focusing: Highly accurate for hemoglobin variant identification 3
• Cellulose acetate electrophoresis at alkaline pH: Traditional method with 100% sensitivity 2

Critical Confirmatory Testing

A specific test for HbS must always be performed to confirm the diagnosis, even after initial hemoglobin separation 1. The two confirmatory options are:

• Solubility test: Detects the sickling property of HbS
• Agar gel electrophoresis at acidic pH: Differentiates HbS from other variants with similar migration patterns

This two-step approach is essential because other hemoglobin variants can co-migrate with HbS on initial testing, leading to misdiagnosis 1.

Quantitative Parameters for Classification

HbA2 levels ≥4.0% are the most efficient discriminator between sickle cell anemia (HbSS) and sickle-β-thalassemia (HbSβ), with 95.2% sensitivity and 96.5% specificity 2. This quantitative distinction is critical for accurate phenotype classification and prognostication.

The typical hemoglobin patterns are 4:

• HbSS (sickle cell anemia): 80-95% HbS, 0% HbA, 5-15% HbF, HbA2 <3-5%
• HbSC disease: 50-55% HbS, 40-45% HbC, <3% HbF
• HbSβ⁰-thalassemia: 80-90% HbS, 0% HbA, 5-15% HbF, HbA2 >3-5%
• HbSβ⁺-thalassemia: 70-80% HbS, 10-25% HbA, HbA2 >3-5%

Molecular Testing Indications

Molecular analysis of the β-globin gene (HBB) should be performed in specific circumstances 2:

• Cases with >50% S-window peaks on CE-HPLC requiring differentiation between HbSS and HbSβ-thalassemia
• Discrepant results between different testing methods
• Complex cases with atypical presentations
• Prenatal diagnosis and genetic counseling

The most common β-thalassemia mutation found in compound heterozygotes is HBB:c.92+5G>C (58.4% of cases) 2.

Common Diagnostic Pitfalls

Avoid these critical errors:

1. Never rely on screening tests alone: Solubility tests and sickling tests are screening tools only and lack specificity to distinguish between sickle cell trait (HbAS) and disease states 5, 6

2. Beware of molecular testing artifacts: PCR-RFLP can produce false results due to loss of restriction enzyme sites 2

3. Consider conditions affecting HbA1c: In patients with sickle cell disease, HbA1c testing for diabetes monitoring is unreliable due to altered red cell turnover; plasma glucose criteria must be used instead 7, 8

4. Timing matters: Newborn screening samples should use dried blood spots or liquid blood, with mandatory confirmatory testing on a second sample to establish definitive diagnosis 3

Optimal Laboratory Algorithm

1. Initial separation: CE-HPLC (preferred) or isoelectric focusing to identify and quantify hemoglobin variants
2. Confirmatory test: Solubility test or agar gel electrophoresis to verify HbS presence
3. Quantitative analysis: Measure HbA2 levels to distinguish HbSS from HbSβ-thalassemia (cutoff ≥4.0%)
4. Molecular testing: Reserve for cases with >50% HbS, discrepant results, or when precise genotype determination affects management
5. Parental testing: Obtain parental HPLC when diagnosis remains uncertain 2

The combination of CE-HPLC with specific HbS confirmation provides both the qualitative identification (presence of HbS) and quantitative characterization (percentages of all hemoglobin fractions) necessary for definitive diagnosis and accurate phenotype classification of sickle cell disorders 2, 1.